Opinion

Latest News

February 18th 2009

It has been said that one should never miss an opportunity to make the most of a crisis. The steady stream of headlines announcing staff cuts, delays in drug approvals and a narrowing of R&D focus for pharmaceutical and biotech companies indicate there will be no shortage of opportunities in 2009.

February 18th 2009

Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy

By Dean Erhardt, MBA, D2 Pharma Consulting LLC

Opinion

Latest News

Trending on Pharmaceutical Commerce

How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy

Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences

Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance

Mid-Year Check-In: Has Prior Auth Reform Delivered?

Mid-Year Check-In: Is Patient Affordability Getting Worse?